(Q44164218)

30 November 2017

title

Unusual radiation response of gemcitabine-treated HeLa cells: reduced and enhanced survival (English)

1 reference

30 November 2017

Shung-jun Yang

1

1 reference

30 November 2017

Xiaoliang Zhang

2

1 reference

30 November 2017

Mingliang Jiang

3

1 reference

30 November 2017

Hani Ashamalla

4

1 reference

30 November 2017

Sameer Rafla

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

187

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

179-183

1 reference

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900454-8

7 January 2021

Radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) within the cell cycle in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900454-8

7 January 2021

The effect of 2'-2' difluorodeoxycytidine (dFdC, gemcitabine) on radiation-induced cell lethality in two human head and neck squamous carcinoma cell lines differing in intrinsic radiosensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900454-8

7 January 2021

Mean inactivation dose: a useful concept for intercomparison of human cell survival curves

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900454-8

7 January 2021

Preclinical characteristics of gemcitabine.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900454-8

7 January 2021

Maximizing therapeutic gain with gemcitabine and fractionated radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900454-8

7 January 2021

10.1016/S0304-3835(02)00454-8

Identifiers

DOI

1 reference

30 November 2017

1 reference